Drugs / Epoetin alpha or beta (Epoetin group)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02049346 Comparator | Mar 2012 → Apr 2013 | anemia due to chronic disorder | Hamad Medical Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epoetin alpha or beta (Epoetin group) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02049346 ↗ |